Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Depreciation & Amortization - Total (2018 - 2023)

Viemed Healthcare's Depreciation & Amortization - Total history spans 6 years, with the latest figure at $419000.0 for Q3 2023.

  • For Q3 2023, Depreciation & Amortization - Total rose 43.99% year-over-year to $419000.0; the TTM value through Jun 2024 reached $419000.0, down 91.95%, while the annual FY2022 figure was $15.6 million, 1736.66% up from the prior year.
  • Depreciation & Amortization - Total reached $419000.0 in Q3 2023 per VMD's latest filing, up from $298000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization - Total ranged from a high of $4.4 million in Q4 2022 to a low of -$7.3 million in Q4 2021.
  • Average Depreciation & Amortization - Total over 5 years is $17736.8, with a median of $237000.0 recorded in 2022.
  • Peak YoY movement for Depreciation & Amortization - Total: skyrocketed 579.61% in 2019, then plummeted 2909.95% in 2020.
  • A 5-year view of Depreciation & Amortization - Total shows it stood at $211000.0 in 2019, then tumbled by 2909.95% to -$5.9 million in 2020, then dropped by 23.82% to -$7.3 million in 2021, then surged by 159.57% to $4.4 million in 2022, then crashed by 90.42% to $419000.0 in 2023.
  • Per Business Quant, the three most recent readings for VMD's Depreciation & Amortization - Total are $419000.0 (Q3 2023), $298000.0 (Q2 2023), and $240000.0 (Q1 2023).